Download PDF
Semin Reprod Med 2017; 35(01): 110-116
DOI: 10.1055/s-0036-1597120
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cancer Implications for Patients with Endometriosis

Mary Ann Wilbur
1   Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medicine, Baltimore, Maryland
,
Ie-Ming Shih
2   Gynecologic Pathology Laboratory, Department of Gynecology and Obstetrics, Johns Hopkins Medicine; Baltimore, Maryland
,
James H. Segars
3   Department of Gynecology and Obstetrics, Johns Hopkins Medicine; Baltimore, Maryland
,
Amanda N. Fader
1   Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medicine, Baltimore, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
03 January 2017 (online)

    Permissions and Reprints

Abstract

Endometriosis is defined as the presence of viable endometrial glands and stroma outside of the uterus. It is a common disease, occurring in 5 to 15% of all women. Endometriosis is associated with chronic pelvic pain and infertility and often requires surgical intervention for definitive treatment. Although it is a benign gynecologic condition, endometriosis shares pathophysiologic features with cancer. In recent years, both histologic and epidemiologic evidence has accumulated, suggesting that ovarian endometriosis may give rise to malignant ovarian tumors, primarily those that are epithelial in origin, known as endometriosis-associated ovarian carcinoma (EAOC) including ovarian clear cell carcinoma, endometrioid carcinoma, and the least common, seromucinous tumors. Women with endometriosis have a two- to threefold increase in absolute risk of developing epithelial ovarian cancer, especially clear cell and endometrioid subtypes. Somatic mutations, such as ARID1A, PIK3CA, and PTEN, may promote the progression of benign endometriosis to carcinoma. Endometriosis has been implicated in the development of other malignancies, including endometrial and breast cancer. In this review, we critically appraise the data regarding the association between endometriosis and ovarian cancer and the potential correlation of endometriosis with other cancers.

Keywords

endometriosis - ovarian cancer - cancer risk
 

  • References

  • 1 Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 2014; 110 (7) 1878-1890
    CrossrefPubMedGoogle Scholar
  • 2 Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364 (9447) 1789-1799
    CrossrefPubMedGoogle Scholar
  • 3 Olive DL, Schwartz LB. Endometriosis. N Engl J Med 1993; 328 (24) 1759-1769
    CrossrefPubMedGoogle Scholar
  • 4 Gazvani R, Templeton A. New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet 2002; 76 (2) 117-126
    CrossrefPubMedGoogle Scholar
  • 5 Somigliana E, Vigano' P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 2006; 101 (2) 331-341
    CrossrefPubMedGoogle Scholar
  • 6 del Carmen MG, Smith Sehdev AE, Nickles Fader A , et al. Endometriosis-Associated Ovarian Carcinoma: Differential Expression of Vascular Endothelial Growth Factor and Estrogen/Progesterone Receptors. American Cancer Society; 2003: 1658-1663
    Google Scholar
  • 7 Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351 (24) 2519-2529
    CrossrefPubMedGoogle Scholar
  • 8 Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002; 955: 281-292, discussion 293–295, 396–406
    CrossrefPubMedGoogle Scholar
  • 9 Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001; 357 (9255) 539-545
    CrossrefPubMedGoogle Scholar
  • 10 Kats R, Collette T, Metz CN, Akoum A. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril 2002; 78 (1) 69-76
    CrossrefPubMedGoogle Scholar
  • 11 Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988; 50 (4) 573-579
    CrossrefPubMedGoogle Scholar
  • 12 Harada T, Yoshioka H, Yoshida S , et al. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997; 176 (3) 593-597
    CrossrefPubMedGoogle Scholar
  • 13 Akoum A, Lemay A, McColl S, Turcot-Lemay L, Maheux R. Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1996; 66 (1) 17-23
    CrossrefPubMedGoogle Scholar
  • 14 Nowak M, Glowacka E, Szpakowski M , et al. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors. Neuroendocrinol Lett 2010; 31 (3) 375-383
    PubMedGoogle Scholar
  • 15 Clendenen TV, Lundin E, Zeleniuch-Jacquotte A , et al. Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011; 20 (5) 799-810
    CrossrefPubMedGoogle Scholar
  • 16 Szlosarek PW, Grimshaw MJ, Kulbe H , et al. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther 2006; 5 (2) 382-390
    CrossrefPubMedGoogle Scholar
  • 17 Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 2016; 186 (4) 733-747
    CrossrefPubMedGoogle Scholar
  • 18 American Cancer Society. Cancer facts & figures 2015. Atlanta, GA: American Cancer Society; 2015
    Google Scholar
  • 19 Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51 (1) 15-36
    CrossrefPubMedGoogle Scholar
  • 20 Brinton LA, Westhoff CL, Scoccia B , et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005; 16 (4) 500-507
    CrossrefPubMedGoogle Scholar
  • 21 Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 2008; 19 (10) 1357-1364
    CrossrefPubMedGoogle Scholar
  • 22 Kobayashi H. Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer. Reprod Med Biol 2010; 9 (1) 17-22
    CrossrefPubMedGoogle Scholar
  • 23 Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3 (2) 93-110 , 43
    PubMedGoogle Scholar
  • 24 Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 1979; 53 (3) 318-323
    PubMedGoogle Scholar
  • 25 LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19 (9) 1080-1084
    CrossrefPubMedGoogle Scholar
  • 26 Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75 (6) 1023-1028
    PubMedGoogle Scholar
  • 27 Oxholm D, Knudsen UB, Kryger-Baggesen N, Ravn P. Postmenopausal endometriosis. Acta Obstet Gynecol Scand 2007; 86 (10) 1158-1164
    CrossrefPubMedGoogle Scholar
  • 28 Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999; 72 (6) 961-969
    CrossrefPubMedGoogle Scholar
  • 29 Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 2012; 124 (1) 164-169
    CrossrefPubMedGoogle Scholar
  • 30 Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003; 189 (1) 280-294
    CrossrefPubMedGoogle Scholar
  • 31 Zeitoun K, Takayama K, Sasano H , et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998; 83 (12) 4474-4480
    CrossrefPubMedGoogle Scholar
  • 32 Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993; 169 (6) 1545-1549
    CrossrefPubMedGoogle Scholar
  • 33 Xiong W, Zhang L, Yu L , et al. Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis. Reproduction 2015; 150 (6) 507-516
    CrossrefPubMedGoogle Scholar
  • 34 Ogawa S, Kaku T, Amada S , et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77 (2) 298-304
    CrossrefPubMedGoogle Scholar
  • 35 Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30 (3) 249-255
    CrossrefPubMedGoogle Scholar
  • 36 Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006; 19 (1) 83-89
    CrossrefPubMedGoogle Scholar
  • 37 Wu RC, Wang TL, Shih IeM. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther 2014; 15 (6) 655-664
    CrossrefPubMedGoogle Scholar
  • 38 Jones S, Wang TL, Shih IeM , et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330 (6001) 228-231
    CrossrefPubMedGoogle Scholar
  • 39 Mao TL, Shih IeM. The roles of ARID1A in gynecologic cancer. J Gynecol Oncol 2013; 24 (4) 376-381
    CrossrefPubMedGoogle Scholar
  • 40 Wiegand KC, Shah SP, Al-Agha OM , et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363 (16) 1532-1543
    CrossrefPubMedGoogle Scholar
  • 41 Ayhan A, Mao TL, Seckin T , et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer 2012; 22 (8) 1310-1315
    CrossrefPubMedGoogle Scholar
  • 42 Chandler RL, Damrauer JS, Raab JR , et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun 2015; 6: 6118
    CrossrefPubMedGoogle Scholar
  • 43 Jiang X, Hitchcock A, Bryan EJ , et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996; 56 (15) 3534-3539
    PubMedGoogle Scholar
  • 44 Li J, Yen C, Liaw D , et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275 (5308) 1943-1947
    CrossrefPubMedGoogle Scholar
  • 45 Sato N, Tsunoda H, Nishida M , et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000; 60 (24) 7052-7056
    PubMedGoogle Scholar
  • 46 Vercellini P, Parazzini F, Bolis G , et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993; 169 (1) 181-182
    CrossrefPubMedGoogle Scholar
  • 47 Vlahos NF, Economopoulos KP, Fotiou S. Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. Best Pract Res Clin Obstet Gynaecol 2010; 24 (1) 39-50
    CrossrefPubMedGoogle Scholar
  • 48 Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer: a review. Gynecol Endocrinol 2010; 26 (3) 213-219
    CrossrefPubMedGoogle Scholar
  • 49 Worley MJ, Welch WR, Berkowitz RS, Ng SW. Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci 2013; 14 (3) 5367-5379
    CrossrefPubMedGoogle Scholar
  • 50 Burghaus S, Häberle L, Schrauder MG , et al. Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study. BMC Cancer 2015; 15: 751-759
    CrossrefPubMedGoogle Scholar
  • 51 Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L, Missmer SA . Endometriosis: a high-risk population for major chronic disease?. Hum Reprod Update 2015; 0 (0) 1-17
    PubMedGoogle Scholar
  • 52 Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gynecol 2011; 2011: 140310
    PubMedGoogle Scholar
  • 53 Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM. The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand 2014; 93 (1) 20-31
    CrossrefPubMedGoogle Scholar
  • 54 Brinton LA, Lamb EJ, Moghissi KS , et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004; 82 (2) 405-414
    CrossrefPubMedGoogle Scholar
  • 55 Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176 (3) 572-579
    CrossrefPubMedGoogle Scholar
  • 56 Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999; 354 (9190) 1586-1590
    CrossrefPubMedGoogle Scholar
  • 57 Ness RB, Grisso JA, Cottreau C , et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000; 11 (2) 111-117
    CrossrefPubMedGoogle Scholar
  • 58 Ness RB, Cramer DW, Goodman MT , et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155 (3) 217-224
    CrossrefPubMedGoogle Scholar
  • 59 Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and its treatment with danazol or Lupron in relation to ovarian cancer. Clin Cancer Res 2003; 9 (14) 5142-5144
    PubMedGoogle Scholar
  • 60 Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 2004; 83 (4) 395-400
    CrossrefPubMedGoogle Scholar
  • 61 Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004; 191 (3) 733-740
    CrossrefPubMedGoogle Scholar
  • 62 Melin A, Sparén P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006; 21 (5) 1237-1242
    CrossrefPubMedGoogle Scholar
  • 63 Melin A, Sparén P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007; 22 (11) 3021-3026
    CrossrefPubMedGoogle Scholar
  • 64 Kobayashi H, Sumimoto K, Moniwa N , et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007; 17 (1) 37-43
    CrossrefPubMedGoogle Scholar
  • 65 Merritt MA, Green AC, Nagle CM, Webb PM ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 2008; 122 (1) 170-176
    CrossrefPubMedGoogle Scholar
  • 66 Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC ; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 2008; 44 (16) 2477-2484
    CrossrefPubMedGoogle Scholar
  • 67 Aris A. Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res 2010; 3 (1) 2
    CrossrefPubMedGoogle Scholar
  • 68 Gemmill JA, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Cancers, infections, and endocrine diseases in women with endometriosis. Fertil Steril 2010; 94 (5) 1627-1631
    CrossrefPubMedGoogle Scholar
  • 69 Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol 2011; 123 (2) 200-204
    CrossrefPubMedGoogle Scholar
  • 70 Pearce CL, Templeman C, Rossing MA , et al; Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13 (4) 385-394
    CrossrefPubMedGoogle Scholar
  • 71 Buis CC, van Leeuwen FE, Mooij TM, Burger CW ; OMEGA Project Group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 2013; 28 (12) 3358-3369
    CrossrefPubMedGoogle Scholar
  • 72 Viganò P, Somigliana E, Parazzini F, Vercellini P. Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer. Fertil Steril 2007; 88 (3) 588-593
    CrossrefPubMedGoogle Scholar
  • 73 Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 2008; 90 (5) 1559-1570
    CrossrefPubMedGoogle Scholar
  • 74 Kumar S, Munkarah A, Arabi H , et al. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 2011; 204 (1) 63.e1-63.e7
    CrossrefPubMedGoogle Scholar
  • 75 Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371 (9612) 569-578
    CrossrefPubMedGoogle Scholar
  • 76 Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114 (1) 121-127
    CrossrefPubMedGoogle Scholar
  • 77 Zucchetto A, Serraino D, Polesel J , et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev 2009; 18 (4) 316-321
    CrossrefPubMedGoogle Scholar
  • 78 Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993; 22 (6) 1000-1009
    CrossrefPubMedGoogle Scholar
  • 79 Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 1997; 70 (2) 150-154
    CrossrefPubMedGoogle Scholar
  • 80 Weiss HA, Brinton LA, Potischman NA , et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999; 28 (5) 816-823
    CrossrefPubMedGoogle Scholar
  • 81 Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer 2002; 94 (5) 1612-1618
    CrossrefPubMedGoogle Scholar
  • 82 Bertelsen L, Mellemkjaer L, Frederiksen K , et al. Risk for breast cancer among women with endometriosis. Int J Cancer 2007; 120 (6) 1372-1375
    CrossrefPubMedGoogle Scholar
  • 83 Baron JA, Weiderpass E, Newcomb PA , et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001; 12 (10) 875-880
    CrossrefPubMedGoogle Scholar
  • 84 Matta JL, Flores I, Morales LM, Monteiro J, Alvarez-Garriga C, Bayona M. Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk. Mol Cancer Biol 2013; 1 (1) 1
    PubMedGoogle Scholar
  • 85 Wyshak G, Frisch RE. Red hair color, melanoma, and endometriosis: suggestive associations. Int J Dermatol 2000; 39 (10) 798
    PubMedGoogle Scholar
  • 86 Wyshak G, Frisch RE, Albright NL, Albright TE, Schiff I. Reproductive factors and melanoma of the skin among women. Int J Dermatol 1989; 28 (8) 527-530
    CrossrefPubMedGoogle Scholar
  • 87 Frisch RE, Wyshak G, Albert LS, Sober AJ. Dysplastic nevi, cutaneous melanoma, and gynecologic disorders. Int J Dermatol 1992; 31 (5) 331-335
    CrossrefPubMedGoogle Scholar
  • 88 Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. J Neurosurg 2011; 115 (6) 1072-1077
    CrossrefPubMedGoogle Scholar